Patents by Inventor Erick M. Carreira

Erick M. Carreira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230002341
    Abstract: In a method for aromatizing an alicyclic region of a cannabinoid, especially in enantiopure, scalemic and/or racemic form, in particular for aromatizing the cyclohexene group in ?9-THC-C5, ?9-THCA-C5 A, ?9-THCV-C3, ?9-THCVA-C5 A, and/or scalemic or racemic mixtures of these substances, wherein an oxidizing agent is added to the cannabinoid, sulfur is used as the oxidizing agent.
    Type: Application
    Filed: June 14, 2022
    Publication date: January 5, 2023
    Applicants: Swiss CannaPharmaceutical SA, ETH Zürich
    Inventors: Erick M. CARREIRA, Roman SAROTT, Patrick PFAFF, Remo ROTH, Sarah EICHENBERGER, Jürg STÄUBLI
  • Publication number: 20160326101
    Abstract: A process for the synthesis of chiral propargylic alcohols.
    Type: Application
    Filed: May 12, 2016
    Publication date: November 10, 2016
    Inventors: Meinrad Brenner, Erick M. Carreira, Nicka Chinkov, Miriam Lorenzi, Aleksander Warm, Lothar Zimmermann
  • Patent number: 8969550
    Abstract: The invention is directed to a process for the preparation of a cyclic carbamate starting with o-aminobenzyl alcohol and/or a suitable salt thereof, which is reacted with a cyclization agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: March 3, 2015
    Assignee: Lonza Ltd.
    Inventors: Meinrad Brenner, Erick M. Carreira, Nicka Chinkov, Miriam Lorenzi, Aleksander Warm, Lothar Zimmermann
  • Patent number: 8957204
    Abstract: The invention is directed to a process for the preparation of a cyclic carbamate starting with a chiral propargylic alcohol and/or a suitable salt thereof, which is reacted with a cyclization agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction is carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane. Another aspect of the invention is directed to a process for the synthesis of said cyclic carbamate starting described above, wherein also a process for the preparation of the chiral propargylic alcohol is provided.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: February 17, 2015
    Assignee: Lonza Ltd.
    Inventors: Meinrad Brenner, Erick M. Carreira, Nicka Chinkov, Miriam Lorenzi, Aleksander Warm, Lothar Zimmermann
  • Publication number: 20130324763
    Abstract: A process for the synthesis of chiral propargylic alcohols.
    Type: Application
    Filed: October 14, 2011
    Publication date: December 5, 2013
    Applicant: LONZA LTD
    Inventors: Meinrad Brenner, Erick M. Carreira, Nicka Chinkov, Miriam Lorenzi, Aleksander Warm, Lothar Zimmermann
  • Publication number: 20130217875
    Abstract: The invention is directed to a process for the preparation of a cyclic carbamate starting with a chiral propargylic alcohol and/or a suitable salt thereof, which is reacted with a cyclisation agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction is carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane. Another aspect of the invention is directed to a process for the synthesis of said cyclic carbamate starting described above, wherein also a process for the preparation of the chiral propargylic alcohol is provided.
    Type: Application
    Filed: October 14, 2011
    Publication date: August 22, 2013
    Applicant: LONZA LTD
    Inventors: Meinrad Brenner, Erick M. Carreira, Nicka Chinkov, Miriam Lorenzi, Aleksander Warm, Lothar Zimmermann
  • Publication number: 20130211077
    Abstract: The invention is directed to a process for the preparation of a cyclic carbamate starting with o-aminobenzyl alcohol and/or a suitable salt thereof, which is reacted with a cyclisation agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C2-5-alkyl C2-5-carboxylates and mixtures of at least one C2-5-alkyl C2-5-carboxylate with at least one C5-8-alkane.
    Type: Application
    Filed: October 14, 2011
    Publication date: August 15, 2013
    Applicant: LONZA LTD
    Inventors: Meinrad Brenner, Erick M. Carreira, Nicka Chinkov, Miriam Lorenzi, Aleksander Warm, Lothar Zimmermann
  • Patent number: 8044224
    Abstract: The invention relates to a chiral iridium aqua complex of formula (1): wherein R1 and R2 are the same or different and each is an aryl group optionally having at least one substituent selected from the group consisting of a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a haloalkoxy group having 1 to 6 carbon atoms, a nitro group, a carboxyl group and a cyano group, or the like; and wherein R3 and R4 are the same or different and each is an alkyl group or the like, as well as the use of such a chiral iridium aqua complex for asymmetric transfer hydrogenation.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: October 25, 2011
    Assignees: Sumitomo Chemical Company, Limited
    Inventor: Erick M. Carreira
  • Publication number: 20110137049
    Abstract: The invention provides a chiral iridium aqua complex which has good preservation stability, can be easily produced, and enables asymmetric transfer hydrogenation in a higher yield and with higher stereoselectivity.
    Type: Application
    Filed: July 6, 2009
    Publication date: June 9, 2011
    Applicants: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventor: Erick M. Carreira
  • Publication number: 20110054171
    Abstract: Salts of optically active [4-(2-diphenylphosphanylnaphthalen-1-yl)phthalazin-1-yl]-(1-phenylethyl)amines represented by the formulas (1) to (4) with an optically active organic sulfonic acid, and a production method thereof.
    Type: Application
    Filed: January 14, 2009
    Publication date: March 3, 2011
    Applicant: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Erick M. Carreira, Shoji Fukuyo, Hiroshi Kadono, Kazuo Murakami
  • Patent number: 7863443
    Abstract: The present invention provides a production method of an allylic amine represented by the formula (III): wherein R3 is as defined in the specification, which comprises reacting by an allylic alcohol represented by the formula (II): wherein R3 is as defined in the specification, with sulfamic acid, in the presence of a phosphoramidite ligand represented by the formula (I): wherein each symbol is as defined in the specification, and an iridium complex. According to the present invention, a primary allylic amine can be produced directly from an allylic alcohol, without use of an activator for an allylic alcohol and conversion of an allylic alcohol into an activated compound thereof.
    Type: Grant
    Filed: March 10, 2008
    Date of Patent: January 4, 2011
    Assignees: Sumitomo Chemical Company, Limited
    Inventor: Erick M. Carreira
  • Patent number: 7790900
    Abstract: An optically active nitro compound having two hydrogen atoms on its ?-carbon atom and having ?-asymmetric carbon atom can be produced by making ?,?-unsaturated nitroolefin having a hydrogen atom on its ?-carbon atom react with at least two organosilicon compounds having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex, or react with an organosilicon compound having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex and water.
    Type: Grant
    Filed: May 17, 2004
    Date of Patent: September 7, 2010
    Assignees: Sumitomo Chemical Company, Limited
    Inventor: Erick M. Carreira
  • Patent number: 7790882
    Abstract: The present invention provides a compound represented by the formula (I): wherein ring A is void or a benzene ring optionally having substituent(s), R1 and R2 are each independently a phenyl group optionally having substituent(s), a cyclohexyl group and the like, R3 and R4 are each independently a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group and the like, and X is a residue represented by —OR5 or —NHR6 wherein R5 and R6 are a lower alkyl group optionally having substituent(s), an aralkyl group optionally having substituent(s) and the like, a asymmetric transition metal complex containing the compound as a ligand and a production method of optically active compound using the complex as an asymmetric catalyst.
    Type: Grant
    Filed: June 10, 2005
    Date of Patent: September 7, 2010
    Assignees: Sumitomo Chemical Company, Limited
    Inventor: Erick M. Carreira
  • Publication number: 20100016618
    Abstract: The invention relates to a chiral iridium aqua complex of formula (1): wherein R1 and R2 are the same or different and each is an aryl group optionally having at least one substituent selected from the group consisting of a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a haloalkoxy group having 1 to 6 carbon atoms, a nitro group, a carboxyl group and a cyano group, or the like; and wherein R3 and R4 are the same or different and each is an alkyl group or the like, as well as the use of such a chiral iridium aqua complex for asymmetric transfer hydrogenation.
    Type: Application
    Filed: January 29, 2008
    Publication date: January 21, 2010
    Applicants: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventor: Erick M. Carreira
  • Publication number: 20090054689
    Abstract: The present invention provides a production method of an allylic amine represented by the formula (III): wherein R3 is as defined in the specification, which comprises reacting by an allylic alcohol represented by the formula (II): wherein R3 is as defined in the specification, with sulfamic acid, in the presence of a phosphoramidite ligand represented by the formula (I): wherein each symbol is as defined in the specification, and an iridium complex. According to the present invention, a primary allylic amine can be produced directly from an allylic alcohol, without use of an activator for an allylic alcohol and conversion of an allylic alcohol into an activated compound thereof.
    Type: Application
    Filed: March 10, 2008
    Publication date: February 26, 2009
    Applicants: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventor: Erick M. CARREIRA
  • Patent number: 6939007
    Abstract: The invention provides photochromic bis-naphthopyran compounds as well as methods for their manufacture and their use. The bis-naphthopyran compounds of the invention exhibit a wide range of color, i.e., from pink to purple to blue gray, upon activation by a source of UV light. Additionally, the bis-naphthopyran compounds of the present invention exhibit broad coloration ability, fast response as to both color change on activation and return to original color, and good fatigue-resistance.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: September 6, 2005
    Inventors: Weili Zhao, Erick M. Carreira
  • Patent number: 6803471
    Abstract: The present invention provides indolinospiropyran compounds and methods for their manufacture, which compounds are useful as photochromic compounds. The compounds of the invention are substituted on the indole ring with succinimide, which substitution permits ring opening of the succinimide and modulation of the bulk and photochromic properties of the compounds. The compounds may be conveniently prepared using the solid phase organic synthesis of the invention.
    Type: Grant
    Filed: January 28, 2002
    Date of Patent: October 12, 2004
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Erick M. Carreira, Weili Zhao
  • Patent number: 6747145
    Abstract: The invention provides photochromic bis-naphthopyran compounds as well as methods for their manufacture and their use. The bis-naphthopyran compounds of the invention exhibit a wide range of color, i.e., from pink to purple to blue gray, upon activation by a source of UV light. Additionally, the bis-naphthopyran compounds of the present invention exhibit broad coloration ability, fast response as to both color change on activation and return to original color, and good fatigue-resistance.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: June 8, 2004
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Weili Zhao, Erick M. Carreira
  • Publication number: 20040084660
    Abstract: The invention provides photochromic bis-naphthopyran compounds as well as methods for their manufacture and their use. The bis-naphthopyran compounds of the invention exhibit a wide range of color, i.e., from pink to purple to blue gray, upon activation by a source of UV light. Additionally, the bis-naphthopyran compounds of the present invention exhibit broad coloration ability, fast response as to both color change on activation and return to original color, and good fatigue-resistance.
    Type: Application
    Filed: October 28, 2003
    Publication date: May 6, 2004
    Inventors: Weili Zhao, Erick M. Carreira
  • Patent number: 6720420
    Abstract: The present invention provides oxazine compounds having aromatic, heteroaromatic, or aliphatic substituents at the 2 position of the oxazine moiety.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: April 13, 2004
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Weili Zhao, Erick M. Carreira